Filing Flows › VitaNova Life Sciences (VNOV) › Q2 FY26
VitaNova Life Sciences (VNOV) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Dec 15, 2025
VitaNova Life Sciences (VNOV) reported revenue of $427K for the second quarter fiscal 2026 (Q2 FY26), +46% from a year earlier and +311% from the quarter before. Operating margin was 23.2%, net earnings $36K (8.4% of revenue).
VitaNova Life Sciences, Q2 FY26: revenue $427K (+46% year over year), operating margin 23.2%, net earnings $36K, operating cash flow $213K. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $427K | +311% | +46% |
| Gross profit | $261K | +279% | +67% |
| Operating profit | $99K | — | +58% |
| Net earnings | $36K | — | +10% |
| Operating cash flow | $213K | -19% | 24× |
What changed
Revenue was $427K in Q2 FY26, up 46% year over year and up 311% from the previous quarter. Sale of Healthcare Products was the largest line at 98% of revenue. Sale of Healthcare Products added $132K year over year (up 46%), 98% of the total change.
Gross margin was 61.1%, up 7.7 points from a year earlier. Operating profit was $99K, a 23.2% margin (up 1.8 points year over year). Of the extra revenue versus a year earlier, 27% reached operating profit, above the 21% margin then. Operating expenses grew 73% against revenue growth of 46%. The fastest-growing cost line was Sales & marketing (+1724%). Net earnings were $36K, up 10% year over year. The effective tax rate was 63.9%.
Operating cash flow was $213K (up 2328% year over year), 594% of net earnings. Working capital and other items added $177K.
Questions
What was VitaNova Life Sciences' revenue in the second quarter fiscal 2026?
VitaNova Life Sciences (VNOV) reported revenue of $427K for the second quarter fiscal 2026 (Q2 FY26), +46% from a year earlier and +311% from the quarter before.
Was VitaNova Life Sciences profitable in the second quarter fiscal 2026?
Operating profit was $99K (23.2% of revenue) and net earnings $36K.